Sandra Fitzgerald Marshall, CRNP Clinical Nurse Specialist - Family Health Medicare: Not Enrolled in Medicare Practice Location: 423 Medical Center Dr Sw, Fort Payne, AL 35968 Phone: 256-844-8144 Fax: 256-844-8177 |
News Archive
Mitral valve repair with complete versus partial ring annuloplasty results in lower levels of recurrence in patients with functional mitral regurgitation, conclude US investigators.
Biotechnology Industry Organization President and CEO Jim Greenwood released the following comment on the introduction of the Patent Reform Act of 2011 (S. 23) by Senate Judiciary Committee Chairman Patrick Leahy (D-VT) earlier this week
As the nation grapples with mental health issues in the wake of recent violence, issues related to restricting gun ownership for the mentally ill take shape on Capitol Hill.
BIND Biosciences, Inc. (BIND), a privately held biopharmaceutical company developing best in class therapeutics based on its proprietary targeted nanotechnology platform, announced today that it has secured a $12.4 Million Series C-1 financing. This financing included all of BIND's current investors (including Polaris Venture Partners, Flagship Ventures, ARCH Venture Partners, NanoDimension and DHK Investments) as well as a new venture investor, Endeavour Vision, and private investors.
BioRx, a specialty pharmacy company, has been named one of a small number of approved providers of Berinert®. Berinert® is a plasma-derived concentrate of C1 esterase inhibitor (human) indicated for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE) in adult and adolescent patients. CSL Behring, the manufacturer of Berinert® selected BioRx as part of their distribution network to launch this exciting new product in the United States.
› Verified 6 days ago